DK79887D0 - VECTOR FOR EXPRESSION OF GAMMA INTERFERON IN PATTERN CELLS, PROCEDURE FOR PREPARING THEREOF, THE FOUND PRODUCT AND PHARMACEUTICAL PREPARATION CONTAINING THE GAMMA INTERFERONET - Google Patents

VECTOR FOR EXPRESSION OF GAMMA INTERFERON IN PATTERN CELLS, PROCEDURE FOR PREPARING THEREOF, THE FOUND PRODUCT AND PHARMACEUTICAL PREPARATION CONTAINING THE GAMMA INTERFERONET

Info

Publication number
DK79887D0
DK79887D0 DK079887A DK79887A DK79887D0 DK 79887 D0 DK79887 D0 DK 79887D0 DK 079887 A DK079887 A DK 079887A DK 79887 A DK79887 A DK 79887A DK 79887 D0 DK79887 D0 DK 79887D0
Authority
DK
Denmark
Prior art keywords
gamma
interferonet
vector
expression
preparing
Prior art date
Application number
DK079887A
Other languages
Danish (da)
Other versions
DK79887A (en
Inventor
Therese Faure
Paul Sondermeyer
Werner Altenburger
Jean-Pierre Lecocq
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Publication of DK79887A publication Critical patent/DK79887A/en
Publication of DK79887D0 publication Critical patent/DK79887D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK079887A 1985-06-18 1987-02-17 VECTOR FOR EXPRESSION OF GAMMA INTERFERON IN PATTERN CELLS, PROCEDURE FOR PREPARING THEREOF, THE FOUND PRODUCT AND PHARMACEUTICAL PREPARATION CONTAINING THE GAMMA INTERFERONET DK79887D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8509225A FR2583429B1 (en) 1985-06-18 1985-06-18 INTERFERON U EXPRESSION VECTOR IN MAMMALIAN CELLS, PROCESS FOR IMPLEMENTING SAME AND PRODUCT OBTAINED, AND PHARMACEUTICAL COMPOSITION CONTAINING INTERFERON U
PCT/FR1986/000207 WO1986007609A1 (en) 1985-06-18 1986-06-16 VECTOR FOR THE EXPRESSION OF gamma-INTERFERON IN MAMMAL CELLS, METHOD FOR ITS IMPLEMENTATION, PRODUCT OBTAINED AND PHARMACEUTICAL COMPOSITION CONTAINING THE gamma-INTERFERON

Publications (2)

Publication Number Publication Date
DK79887A DK79887A (en) 1987-02-17
DK79887D0 true DK79887D0 (en) 1987-02-17

Family

ID=9320362

Family Applications (1)

Application Number Title Priority Date Filing Date
DK079887A DK79887D0 (en) 1985-06-18 1987-02-17 VECTOR FOR EXPRESSION OF GAMMA INTERFERON IN PATTERN CELLS, PROCEDURE FOR PREPARING THEREOF, THE FOUND PRODUCT AND PHARMACEUTICAL PREPARATION CONTAINING THE GAMMA INTERFERONET

Country Status (7)

Country Link
EP (1) EP0206920A1 (en)
JP (1) JPS63500003A (en)
AU (1) AU5957986A (en)
DK (1) DK79887D0 (en)
FR (1) FR2583429B1 (en)
WO (1) WO1986007609A1 (en)
ZA (1) ZA864525B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833975A (en) * 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
ATE132534T1 (en) * 1986-08-01 1996-01-15 Commw Scient Ind Res Org RECOMBINANT VACCINE
JPS6363381A (en) * 1986-09-04 1988-03-19 Kokuritsu Yobou Eisei Kenkyusho Recombinant vaccinia virus
FR2632863B2 (en) * 1987-10-29 1990-08-31 Transgene Sa RECOMBINANT FOWLPOX VIRUS AND VACCINES DERIVED FROM SUCH VIRUSES
FR2622456B1 (en) * 1987-10-29 1990-02-02 Transgene Sa RECOMBINANT FOWLPOX VIRUSES, HETEROLOGOUS PROTEIN EXPRESSION VECTORS AND POULTRY VACCINES DERIVED FROM THIS VIRUS
US5662896A (en) * 1988-03-21 1997-09-02 Chiron Viagene, Inc. Compositions and methods for cancer immunotherapy
EP0469089B1 (en) * 1989-04-18 1997-11-19 Applied Biotechnology, Inc. Generation of hybrid genes and proteins by virus-mediated recombination
GB8915870D0 (en) * 1989-07-11 1989-08-31 Nat Res Dev Dna coding for a polypeptide signal sequence in vaccinia virus
DE4002521A1 (en) * 1990-01-29 1991-08-01 Immuno Ag Recombinant plasmids for pox virus transformation - contg. multifunctional DNA sequence cassette to facilitate cloning of foreign DNA
FR2710536B1 (en) * 1993-09-29 1995-12-22 Transgene Sa Anti-cancer use of a viral vector comprising a gene which modulates the immune and / or inflammatory response.
WO1995031105A1 (en) * 1994-05-13 1995-11-23 Thomas Jefferson University A method of inducing an immune response using vaccinia virus recombinants
US6093700A (en) 1995-05-11 2000-07-25 Thomas Jefferson University Method of inducing an immune response using vaccinia virus recombinants encoding GM-CSF
FR2766091A1 (en) 1997-07-18 1999-01-22 Transgene Sa ANTITUMOR COMPOSITION BASED ON MODIFIED IMMUNOGENIC POLYPEPTIDE WITH CELL LOCATION
AU5446700A (en) 1999-05-28 2000-12-18 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The A combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector
EP1925626A1 (en) 2003-07-21 2008-05-28 Transgene S.A. Novel multifunctional cytokines
EP1897938B9 (en) * 2003-07-21 2011-08-31 Transgene SA Polypeptide having an improved cytosine deaminase activity
US8470977B2 (en) 2008-03-14 2013-06-25 Transgene S.A. Antibody against the CSF-1R
MX2011007494A (en) 2009-01-13 2011-08-12 Transgene Sa Use of a saccharomyces cerevisiae mitochondrial nucleic acids fraction for immune stimulation.
US9051359B2 (en) 2009-03-30 2015-06-09 Icahn School Of Medicine At Mount Sinai Influenza virus vaccines and uses thereof
CN102573903B (en) 2009-08-07 2015-12-02 特兰斯吉恩股份有限公司 Be used for the treatment of the compositions of HBV infection
EP3900740A1 (en) 2010-03-30 2021-10-27 Icahn School of Medicine at Mount Sinai Influenza virus vaccines and uses thereof
EA201490659A1 (en) 2011-09-20 2014-11-28 Маунт Синай Скул Оф Медсин VACCINES AGAINST FLU VIRUS AND THEIR USE
WO2013083254A1 (en) 2011-12-09 2013-06-13 Bavarian Nordic A/S Poxvirus vector for the expression of bacterial antigens linked to tetanus toxin fragment c
CN109134640A (en) 2012-10-23 2019-01-04 爱默蕾大学 GM-CSF and IL-4 conjugates, composition and relative method
CN108641002A (en) 2012-12-18 2018-10-12 西奈山伊坎医学院 Influenza virus vaccine and application thereof
CN110418650A (en) 2016-11-16 2019-11-05 免疫治疗有限公司 For treating the nucleic acid of allergy
JP7222915B2 (en) 2017-05-02 2023-02-15 イミュノミック セラピューティックス， インコーポレイテッド Improved LAMP constructs containing cancer antigens
JP2021523185A (en) 2018-05-15 2021-09-02 イミュノミック セラピューティックス， インコーポレイテッドＩｍｍｕｎｏｍｉｃ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． Improved LAMP constructs containing allergens
US20240108703A1 (en) 2019-10-18 2024-04-04 Immunomic Therapeutics, Inc. Improved LAMP Constructs Comprising Cancer Antigens
WO2023201201A1 (en) 2022-04-10 2023-10-19 Immunomic Therapeutics, Inc. Bicistronic lamp constructs comprising immune response enhancing genes and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
EP0088540A3 (en) * 1982-02-22 1984-10-17 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing human immune interferon-like polypeptides
WO1984002077A1 (en) * 1982-11-30 1984-06-07 Us Health Process for producing poxvirus recombinants for expression of foreign genes

Also Published As

Publication number Publication date
JPS63500003A (en) 1988-01-07
AU5957986A (en) 1987-01-13
DK79887A (en) 1987-02-17
WO1986007609A1 (en) 1986-12-31
FR2583429B1 (en) 1989-11-03
ZA864525B (en) 1987-03-25
FR2583429A1 (en) 1986-12-19
EP0206920A1 (en) 1986-12-30

Similar Documents

Publication Publication Date Title
DK79887D0 (en) VECTOR FOR EXPRESSION OF GAMMA INTERFERON IN PATTERN CELLS, PROCEDURE FOR PREPARING THEREOF, THE FOUND PRODUCT AND PHARMACEUTICAL PREPARATION CONTAINING THE GAMMA INTERFERONET
DK161709C (en) 13-ALKYL-11BETA-PHENYLGONANES, PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR USE FOR THE PREPARATION OF MEDICINAL PRODUCTS
DK162445C (en) PYRANOPYRIDINES, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THE PYRANOPYRIDINES
DK164868C (en) IMIDAZOOE4,5-BAAQUINOLIN-2-ON DERIVATIVES, PROCEDURE FOR PREPARING THEREOF, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE
DK477686A (en) HETEROPOLYSACCHARID, PROCEDURE FOR PREPARING THEREOF AND USING IT IN A COMPLEX, AND PROCEDURE FOR THE PREPARATION OF SUCH COMPLEX
NZ237198A (en) Zymogen form of protein c, dna, vector and use as a pharmaceutical
DK16386D0 (en) COAT PREPARATIONS AND CONTAINERS FOR USE WITH THE SAME
DK431586D0 (en) BENZIMIDAZOLD DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND THE MEDICINAL PRODUCT CONTAINING THESE
DK642588D0 (en) INDANDER DERIVATIVES, PROCEDURE FOR PREPARING THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
DK163057C (en) ISOINDSOLINYL-ALKYL PIPERAZINES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
DK621486D0 (en) 1-BENZENESULPHONYL-2-OXO-5-ALCOXYPYRROLIDE INGREDIATES AND THEIR PREPARATION, USE AND PREPARATIONS WITH THE CONTENTS
ZA86936B (en) 11beta-phenyl-gonanes,their manufacture and pharmaceutical preparations containing them
DK165985C (en) 1-CYTOSIN DERIVATIVES, PROCEDURES FOR THEIR PREPARATION, AND USE OF THEM IN AND FOR THE PREPARATION OF MEDICINAL PRODUCTS
IL60325A0 (en) Novel quinazoline derivatives and pharmaceutical preparations containing them
ZA803535B (en) Novel quinazoline derivatives and pharmaceutical preparations
DK469189D0 (en) SUBSTITUTED THIENOPYRANES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
DK163121C (en) 1-BENZAZEPIN-2-ON DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING SUCH PRODUCTS AND USING THEM FOR THE PREPARATION OF THE PREPARATIONS
DK163128C (en) PYRIMIDINE NUCLEOSIDES, PROCEDURES FOR PREPARING THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING THE PYRIMIDINE NUCLEOSIDES AND USE OF THE PYRIMIDINE NUCLEOSIDES
DK420986A (en) DIHYDROPYRIDINE-2-HYDROXYAMINES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS
DK334989D0 (en) ANTIVIRAL RELATIONS AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH PRODUCTS.
DK415388D0 (en) PHARMACEUTICAL PREPARATIONS CONTAINING PYRIMIDINE INGREDIENTS AND PROCEDURES FOR PREPARING THEREOF
DK520086D0 (en) PROCEDURE FOR PARTICLE PURIFICATION OF A BIOLOGICALLY ACTIVE PROTEIN, INCLUDING TUMOR CANCER FACTOR, AND THE PRODUCT AND PHARMACEUTICAL PREPARATION CONTAINING THE SAME
DK191086D0 (en) BENZISOSELENAZOLONYL DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE
PH16060A (en) Pyrimidine derivatives and pharmaceutical preparation thereof
DK597784D0 (en) SILANE-MODIFIED ESTER MIXTURES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE IN PHARMACEUTICAL AND COSMETIC PREPARATIONS